Trial Profile
Multiple dose bioequivalence study of epoetin zeta (Hospira) and Epogen in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Epoetin zeta (Primary) ; Epoetin alfa
- Indications Anaemia
- Focus Pharmacodynamics; Pharmacokinetics
- 12 Apr 2016 Results published in the Clinical Therapeutics
- 31 Mar 2015 New trial record
- 27 Mar 2015 Results published in Hospira media release.